Related Experiment Video
Updated: Aug 9, 2025

Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Hallmarks of neurodegenerative diseases
David M Wilson1, Mark R Cookson2, Ludo Van Den Bosch3
1Hasselt University, Biomedical Research Institute, BIOMED, 3500 Hasselt, Belgium.
This study outlines eight key hallmarks of neurodegenerative diseases (NDDs), offering a holistic framework for understanding their mechanisms. This approach aims to improve patient stratification and personalize therapies for effective NDD treatment.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Neurodegenerative diseases (NDDs) involve complex genetic and biochemical pathways.
- Existing research has identified numerous factors contributing to NDDs.
Purpose of the Study:
- To present a unifying framework of eight core hallmarks of NDDs.
- To establish a basis for understanding NDD pathogenesis, classification, and treatment.
Main Methods:
- Literature review and synthesis of existing research on NDDs.
- Identification and description of eight key hallmarks and their biomarkers.
Main Results:
- Eight hallmarks of NDDs identified: protein aggregation, synaptic dysfunction, proteostasis imbalance, cytoskeletal issues, energy metabolism defects, DNA/RNA damage, inflammation, and cell death.
- Interactions between these hallmarks are described.
- Biomarkers for each hallmark are discussed.
Conclusions:
- A holistic framework based on eight hallmarks can advance NDD research.
- This framework supports defining pathogenic mechanisms and categorizing NDDs.
- It facilitates patient stratification and the design of personalized, multi-targeted therapies for NDDs.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Parkinson's Disease: Overview
Neural Regulation
Alzheimer's Disease: Treatment
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Dementia
The progression of dementia is generally gradual....

